Inmolecule NanotechXPAR:MLINA 6 Interest Coverage is 0 (At Loss) as of Dec. 2024. GuruFocus rates XPAR:MLINA with a GF Score™ of 6/100. The stock has 2 warning signs investors should review. Among 377 Biotechnology companies, Inmolecule Nanotech ranks worse than 265251.72% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Inmolecule Nanotech's
Operating Income
for the
six
months ended in Dec. 2024 was €-0.22 Mil. Inmolecule Nanotech's Interest Expense for the
six
months ended in Dec. 2024 was €-0.01 Mil.
did not have earnings to cover the interest expense.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Inmolecule Nanotech's Interest Coverage or its related term are showing as below:
XPAR:MLINA's Interest Coverage is not ranked *
in the Biotechnology industry.
Industry Median: 106.07 * Ranked among companies with meaningful Interest Coverage only.
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Inmolecule Nanotech Interest Coverage Related Terms
Inmolecule Nanotech Interest Coverage Historical Data
* Premium members only.
The historical data trend for Inmolecule Nanotech's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
Inmolecule Nanotech Interest Coverage Chart
Inmolecule Nanotech Annual Data
Trend
Dec23
Dec24
Interest Coverage
0.00
0.00
Inmolecule Nanotech Semi-Annual Data
Dec23
Dec24
Interest Coverage
0.00
0.00
XPAR:MLINA vs VRTX, REGN, ALNY: Interest Coverage Comparison
For the Biotechnology subindustry, Inmolecule Nanotech's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Inmolecule Nanotech Interest Coverage vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Inmolecule Nanotech's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Inmolecule Nanotech's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
Inmolecule Nanotech did not have earnings to cover the interest expense.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Interest Coverage of 0 (At Loss) mean?
Inmolecule Nanotech (XPAR:MLINA) has a Interest Coverage of 0 (At Loss) as of Dec. 2024. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Inmolecule Nanotech and its competitors. According to the industry distribution chart, Inmolecule Nanotech ranks #999999 out of 377 companies in the Biotechnology industry.
Is Inmolecule Nanotech's Interest Coverage too high?
Inmolecule Nanotech's current Interest Coverage is 0 (At Loss). Based on the distribution chart, Inmolecule Nanotech ranks #999999 out of 377 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Inmolecule Nanotech has a GF Score™ of 6/100, reflecting its overall financial health beyond just this single metric.
How does Inmolecule Nanotech's Interest Coverage compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Inmolecule Nanotech ranks #999999 out of 377 companies for Interest Coverage. This places Inmolecule Nanotech in the lower half of its industry. The industry median Interest Coverage is 106.07. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Biotechnology company?
The median Interest Coverage among Biotechnology companies is 106.07, based on 377 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Inmolecule Nanotech and its competitors. For the Biotechnology industry, the median Interest Coverage is 106.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Inmolecule Nanotech's current Interest Coverage is 0 (At Loss). However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Inmolecule Nanotech stock overvalued right now?
Inmolecule Nanotech (XPAR:MLINA) has a current Interest Coverage of 0 (At Loss). The current Interest Coverage is 0 (At Loss). Inmolecule Nanotech's overall GF Score™ is 6/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Inmolecule Nanotech (XPAR:MLINA), the current Interest Coverage is 0 (At Loss) as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XPAR:MLINA has been successfully added to your 